Positional integratomic approach in identification of genomic candidate regions for Parkinson's disease

MOTIVATION Recent abundance of data from studies employing high-throughput technologies to reveal alterations in human disease on genomic, transcriptomic, proteomic and other levels, offer the possibility to integrate this information into a comprehensive picture of molecular events occurring in human disease. Diversity of data originating from these studies presents a methodological obstacle in the integration process, also due to difficulties in choosing the optimal unified denominator that would allow inclusion of variables from various types of studies. We present a novel approach for integration of such multi-origin data based on positions of genetic alterations occurring in human diseases. Parkinson's disease (PD) was chosen as a model for evaluation of our methodology. METHODS Datasets from various types of studies in PD (linkage, genome-wide association, transcriptomic and proteomic studies) were obtained from online repositories or were extracted from available research papers. Subsequently, human genome assembly was subdivided into 10 kb regions, and significant signals from aforementioned studies were arranged into their corresponding regions according to their genomic position. For each region, rank product values were calculated and significance values were estimated by permuting the original dataset. RESULTS Altogether, 179 regions (representing 33 contiguous genomic regions) had significant accumulation of signals when P-value cut-off was set at 0.0001. Identified regions with significant accumulation of signals contained 29 plausible candidate genes for PD. In conclusion, we present a novel approach for identification of candidate regions and genes for various human disorders, based on the positional integration of data across various types of omic studies.

[1]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[2]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[3]  D. Kleinjan,et al.  Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.

[4]  N. Wood,et al.  Molecular pathogenesis of Parkinson's disease. , 2005, Human molecular genetics.

[5]  B. Peterlin,et al.  Search for sarcoidosis candidate genes by integration of data from genomic, transcriptomic and proteomic studies. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[6]  S. Aizawa,et al.  Characterization of the pufferfish Otx2 cis-regulators reveals evolutionarily conserved genetic mechanisms for vertebrate head specification , 2004, Development.

[7]  Robert Gentleman,et al.  Using GOstats to test gene lists for GO term association , 2007, Bioinform..

[8]  J Khan,et al.  DNA microarray technology: the anticipated impact on the study of human disease. , 1999, Biochimica et biophysica acta.

[9]  Jianhe Peng,et al.  Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function , 2009, Proteomics.

[10]  Bassem A. Hassan,et al.  Gene prioritization through genomic data fusion , 2006, Nature Biotechnology.

[11]  Joyce A. Mitchell,et al.  Using literature-based discovery to identify disease candidate genes , 2005, Int. J. Medical Informatics.

[12]  J. Kordower,et al.  Etiology of Parkinson's disease: Genetics and environment revisited , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Robinson,et al.  The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. , 2008, American journal of human genetics.

[14]  Yan Liu,et al.  Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. , 2006, Journal of Alzheimer's disease : JAD.

[15]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[16]  S. Bhushan,et al.  Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[17]  Mariza de Andrade,et al.  High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.

[18]  F. Middleton,et al.  Integrating genetic, functional genomic, and bioinformatics data in a systems biology approach to complex diseases: application to schizophrenia. , 2007, Methods in molecular biology.

[19]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[20]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[21]  Peilin Jia,et al.  A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case , 2009, Bioinform..

[22]  Patrick Cahan,et al.  Meta-analysis of microarray results: challenges, opportunities, and recommendations for standardization. , 2007, Gene.

[23]  A. Schedl,et al.  Aniridia-associated translocations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6. , 2001, Human molecular genetics.

[24]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[25]  E. Birney,et al.  Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Research.

[26]  R. Verhaak,et al.  A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. , 2007, The Journal of clinical investigation.

[27]  Damian Smedley,et al.  BioMart – biological queries made easy , 2009, BMC Genomics.

[28]  Cornelius J Werner,et al.  Proteome analysis of human substantia nigra in Parkinson's disease , 2008, Proteome Science.

[29]  Dorothea K. Thompson,et al.  DNA Microarray Technology , 2005 .

[30]  Sean R. Davis,et al.  GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..

[31]  Ralf Herwig,et al.  Meta-Analysis Approach identifies Candidate Genes and associated Molecular Networks for Type-2 Diabetes Mellitus , 2008, BMC Genomics.

[32]  Peter J Park,et al.  Improving identification of differentially expressed genes in microarray studies using information from public databases , 2004, Genome Biology.

[33]  Bart De Moor,et al.  A guide to web tools to prioritize candidate genes , 2011, Briefings Bioinform..

[34]  Z. Wszolek,et al.  Genetics of Parkinson disease and essential tremor. , 2010, Current opinion in neurology.

[35]  Sonja W. Scholz,et al.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.

[36]  Á. Jónasdóttir,et al.  A genome wide linkage disequilibrium screen in Parkinson’s disease , 2005, Journal of Neurology.

[37]  V. McKusick Mendelian Inheritance in Man and Its Online Version, OMIM , 2007, The American Journal of Human Genetics.

[38]  Andrew D. Johnson,et al.  Bmc Medical Genetics an Open Access Database of Genome-wide Association Results , 2009 .

[39]  Rainer Breitling,et al.  RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..

[40]  Yan Wang,et al.  Proteomic Identification of a Stress Protein, Mortalin/mthsp70/GRP75 , 2006, Molecular & Cellular Proteomics.

[41]  R. Shukla,et al.  Blood proteome profiling in case controls and Parkinson's disease patients in Indian population. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[42]  Allan I. Levey,et al.  Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases* , 2004, Journal of Biological Chemistry.

[43]  B. Bergamasco,et al.  Proteome analysis of human substantia nigra in Parkinson's disease , 2004, Proteomics.

[44]  E. Lehman Epidemiology of neurodegeneration in American-style professional football players , 2013, Alzheimer's Research & Therapy.

[45]  M. Orešič,et al.  Pathways to the analysis of microarray data. , 2005, Trends in biotechnology.